In October 2019, the New England Journal of Medicine published this paper by Hani Jneid, M.D. It is about the study conducted by Schüpke S, et al. The research follows an open-label multicenter trial that pioneered the comparison of Ticagrelor and Prasugrel as a treatment for sufferers of acute coronary syndromes.
The patients in question were due for invasive evaluation at the time.
The multicenter randomized trial involved the random assignment of either prasugrel or ticagrelor to 4018 patients set to receive an invasive evaluation. The main endpoint had been the …
